Literature DB >> 17392750

Cancer patients opt for unapproved drug.

Helen Pearson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17392750     DOI： 10.1038/446474a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  Mitochondrial metabolism inhibitors for cancer therapy.

Authors:  Emma E Ramsay; Philip J Hogg; Pierre J Dilda
Journal:  Pharm Res       Date:  2011-09-15       Impact factor: 4.200

Review 2.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

3.  Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.

Authors:  F Zwicker; A Kirsner; P Peschke; F Roeder; J Debus; P E Huber; K J Weber
Journal:  Strahlenther Onkol       Date:  2013-06-23       Impact factor: 3.621

Review 4.  Targeting metabolic transformation for cancer therapy.

Authors:  Daniel A Tennant; Raúl V Durán; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

5.  Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.

Authors:  Shanta Dhar; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

6.  Peripheral neuropathy in rats exposed to dichloroacetate.

Authors:  Nigel A Calcutt; Veronica L Lopez; Arjel D Bautista; Leah M Mizisin; Brenda R Torres; Albert L Shroads; Andrew P Mizisin; Peter W Stacpoole
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

7.  Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate.

Authors:  E Babu; S Ramachandran; V CoothanKandaswamy; S Elangovan; P D Prasad; V Ganapathy; M Thangaraju
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

8.  In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds.

Authors:  Ulrike Olszewski; Thomas Tuxen Poulsen; Ernst Ulsperger; Hans Skovgard Poulsen; Klaus Geissler; Gerhard Hamilton
Journal:  Clin Pharmacol       Date:  2010-09-14

9.  Two mixed-NH3/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group.

Authors:  Weiping Liu; Jia Su; Jing Jiang; Xingyao Li; Qingsong Ye; Hongyu Zhou; Jialin Chen; Yan Li
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 10.  Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas.

Authors:  Mithilesh Kumar Jha; Kyoungho Suk
Journal:  Brain Tumor Res Treat       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.